A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902

Authors: Seth A. Rosenthal, Daniel Hunt, Oliver Sartor, Kenneth J. Pienta, Leonard G. Gomella, David J. Grignon, Raghu Rajan, K. Kerlin, Christopher U. Jones, M.C. Dobelbower, William U. Shipley, Kenneth L. Zeitzer, Daniel A. Hamstra, Viroon Donavanik, Marvin Rotman, Alan C. Hartford, Jeffrey Michalski, Michael J. Seider, Harold Kim, Deborah A. Kuban, Jennifer Moughan, Howard M. Sandler - International Journal of Radiation Oncology*Biology*Physics 2015 cited by 78